Natural killer cell deficiency

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 3, 2013, Pages 515-525

  Orange, Jordan S ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

cytotoxicity; innate immunity; natural killer cell deficiency; Natural killer cells; primary immunodeficiency

Indexed keywords

ACICLOVIR; GANCICLOVIR; STAT5B PROTEIN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; CONGENITAL DISORDER; CYTOKINESIS; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; GENE MUTATION; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNOPROPHYLAXIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; VARICELLA ZOSTER VIRUS; WART VIRUS;

ADCC; ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY; CLASSICAL NATURAL KILLER CELL DEFICIENCY; CMV; CNKD; CTL; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DEDICATOR OF CYTOKINESIS 8; DOCK8; FNKD; FUNCTIONAL NATURAL KILLER CELL DEFICIENCY; HERPES SIMPLEX VIRUS; HPV; HSV; HUMAN PAPILLOMAVIRUS; INNATE IMMUNITY; MCM; MINICHROMOSOME MAINTENANCE; NATURAL KILLER; NATURAL KILLER CELL DEFICIENCY; NATURAL KILLER CELLS; NK; NKD; PID; PRIMARY IMMUNODEFICIENCY; VARICELLA ZOSTER VIRUS; VZV;

DISEASE SUSCEPTIBILITY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; KILLER CELLS, NATURAL; VIRUS DISEASES;

EID: 84883232593     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.07.020     Document Type: Review

References (100)

1. E. Vivier, E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini Functions of natural killer cells Nat Immunol 9 2008 503 510
2. G. Min-Oo, Y. Kamimura, D.W. Hendricks, T. Nabekura, and L.L. Lanier Natural killer cells: walking three paths down memory lane Trends Immunol 34 2013 251 258
3. H. Spits, D. Artis, M. Colonna, A. Diefenbach, J.P. Di Santo, and G. Eberl Innate lymphoid cells - a proposal for uniform nomenclature Nat Rev Immunol 13 2013 145 149
4. M.A. Caligiuri Human natural killer cells Blood 112 2008 461 469
5. A.G. Freud, B. Becknell, S. Roychowdhury, H.C. Mao, A.K. Ferketich, and G.J. Nuovo A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells Immunity 22 2005 295 304
6. A. Poli, T. Michel, M. Theresine, E. Andres, F. Hentges, and J. Zimmer CD56bright natural killer (NK) cells: an important NK cell subset Immunology 126 2009 458 465
7. L.L. Lanier Up on the tightrope: natural killer cell activation and inhibition Nat Immunol 9 2008 495 502
8. S. Jost, and M. Altfeld Control of human viral infections by natural killer cells Annu Rev Immunol 31 2013 163 194
9. D. Horst, M.C. Verweij, A.J. Davison, M.E. Ressing, and E.J. Wiertz Viral evasion of T cell immunity: ancient mechanisms offering new applications Curr Opin Immunol 23 2011 96 103
10. P. Parham, and A. Moffett Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution Nat Rev Immunol 13 2013 133 144
11. V.J. Lisnic, A. Krmpotic, and S. Jonjic Modulation of natural killer cell activity by viruses Curr Opin Microbiol 13 2010 530 539
12. O. Mandelboim, N. Lieberman, M. Lev, L. Paul, T.I. Arnon, and Y. Bushkin Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells Nature 409 2001 1055 1060
13. R.A. Lam, J.Y. Chwee, N. Le Bert, M. Sauer, E. Pogge von Strandmann, and S. Gasser Regulation of self-ligands for activating natural killer cell receptors Ann Med 45 2013 384 394
14. J.S. Orange Formation and function of the lytic NK-cell immunological synapse Nat Rev Immunol 8 2008 713 725
15. E. Vivier, D.H. Raulet, A. Moretta, M.A. Caligiuri, L. Zitvogel, and L.L. Lanier Innate or adaptive immunity? The example of natural killer cells Science 331 2011 44 49
16. F.A. Bonilla, I.L. Bernstein, D.A. Khan, Z.K. Ballas, J. Chinen, and M.M. Frank Practice parameter for the diagnosis and management of primary immunodeficiency Ann Allergy Asthma Immunol 94 suppl 2005 S1 S63
17. J.S. Orange Human natural killer cell deficiencies and susceptibility to infection Microbes Infect 4 2002 1545 1558
18. J.S. Orange Human natural killer cell deficiencies Curr Opin Allergy Clin Immunol 6 2006 399 409
19. J.S. Orange Unraveling human natural killer cell deficiency J Clin Invest 122 2012 798 801
20. S.M. Wood, H.G. Ljunggren, and Y.T. Bryceson Insights into NK cell biology from human genetics and disease associations Cell Mol Life Sci 68 2011 3479 3493
21. P.J. Brennan, M. Brigl, and M.B. Brenner Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions Nat Rev Immunol 13 2013 101 117
22. C.A. Biron, K.S. Byron, and J.L. Sullivan Severe herpesvirus infections in an adolescent without natural killer cells N Engl J Med 320 1989 1731 1735
23. H. Akiba, Y. Motoki, M. Satoh, K. Iwatsuki, and F. Kaneko Recalcitrant trichophytic granuloma associated with NK-cell deficiency in a SLE patient treated with corticosteroid Eur J Dermatol 11 2001 58 62
24. Z.K. Ballas, J.M. Turner, D.A. Turner, E.A. Goetzman, and J.D. Kemp A patient with simultaneous absence of "classical" natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset J Allergy Clin Immunol 85 1990 453 459
25. F. Bernard, C. Picard, V. Cormier-Daire, C. Eidenschenk, G. Pinto, and J.C. Bustamante A novel developmental and immunodeficiency syndrome associated with intrauterine growth retardation and a lack of natural killer cells Pediatrics 113 2004 136 141
26. C. Eidenschenk, J. Dunne, E. Jouanguy, C. Fourlinnie, L. Gineau, and D. Bacq A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8 Am J Hum Genet 78 2006 721 727
27. A. Etzioni, C. Eidenschenk, R. Katz, R. Beck, J.L. Casanova, and S. Pollack Fatal varicella associated with selective natural killer cell deficiency J Pediatr 146 2005 423 425
28. S. Min, L. Monaco-Shawver, J. Orange, and J. Church Classical natural killer cell deficiency (CNKD): a new case Clin Immunol 131 suppl 2009 S61
29. L.D. Notarangelo, and E. Mazzolari Natural killer cell deficiencies and severe varicella infection J Pediatr 148 2006 563 564 author reply 4
30. T. Wendland, S. Herren, N. Yawalkar, A. Cerny, and W.J. Pichler Strong αβ and γδ TCR response in a patient with disseminated mycobacterium avium infection and lack of NK cells and monocytopenia Immunol Lett 72 2000 75 82
31. R.K. Shaw, A.C. Issekutz, R. Fraser, P. Schmit, B. Morash, and L. Monaco-Shawver Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency Blood 119 2012 4009 4012
32. K.C. Gilmour, H. Fujii, T. Cranston, E.G. Davies, C. Kinnon, and H.B. Gaspar Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency Blood 98 2001 877 879
33. E.M. Mace, A.P. Hsu, L. Monaco-Shawver, G. Makedonas, J.B. Rosen, and L. Dropulic Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset Blood 121 2013 2669 2677
34. D.C. Vinh, S.Y. Patel, G. Uzel, V.L. Anderson, A.F. Freeman, and K.N. Olivier Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia Blood 115 2010 1519 1529
35. A.P. Hsu, E.P. Sampaio, J. Khan, K.R. Calvo, J.E. Lemieux, and S.Y. Patel Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome Blood 118 2011 2653 2655
36. R.E. Dickinson, H. Griffin, V. Bigley, L.N. Reynard, R. Hussain, and M. Haniffa Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency Blood 118 2011 2656 2658
37. J. Cuellar-Rodriguez, J. Gea-Banacloche, A.F. Freeman, A.P. Hsu, C.S. Zerbe, and K.R. Calvo Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency Blood 118 2011 3715 3720
38. M.A. Spinner, L.A. Sanchez, A.P. Hsu, K.R. Calvo, J. Cuellar-Rodriguez, and D.D. Hickstein GATA2 deficiency: extended clinical phenotype in 57 patients J Clin Immunol 33 2013 672
39. L. Gineau, C. Cognet, N. Kara, F.P. Lach, J. Dunne, and U. Veturi Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency J Clin Invest 122 2012 821 832
40. C.R. Hughes, L. Guasti, E. Meimaridou, C.H. Chuang, J.C. Schimenti, and P.J. King MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans J Clin Invest 122 2012 814 820
41. M.L. Bochman, and A. Schwacha The Mcm complex: unwinding the mechanism of a replicative helicase Microbiol Mol Biol Rev 73 2009 652 683
42. N. Shima, A. Alcaraz, I. Liachko, T.R. Buske, C.A. Andrews, and R.J. Munroe A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice Nat Genet 39 2007 93 98
43. C. Eidenschenk, E. Jouanguy, A. Alcais, J.J. Mention, B. Pasquier, and I.M. Fleckenstein Familial NK cell deficiency associated with impaired IL-2- and IL-15-dependent survival of lymphocytes J Immunol 177 2006 8835 8843
44. G. Fleisher, S. Starr, N. Koven, H. Kamiya, S.D. Douglas, and W. Henle A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections J Pediatr 100 1982 727 730
45. C.I. Domaica, M.B. Fuertes, I. Uriarte, M.V. Girart, J. Sardanons, and D.I. Comas Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development PLoS One 7 2012 e51677
46. A. Komiyama, H. Kawai, A. Yabuhara, Y. Mitsuhiko, Y. Miyagawa, and M. Ota Natural killer cell immunodeficiency in siblings: defective killing in the absence of natural killer cytotoxic factor activity in natural killer and lymphokine-activated killer cytotoxicities Pediatrics 85 1990 323 330
47. B.W. Ornstein, E.B. Hill, T.L. Geurs, and A.R. French Natural killer cell functional defects in pediatric patients with severe and recurrent herpesvirus infections J Infect Dis 207 2013 458 468
48. C. Lopez, D. Kirkpatrick, S.E. Read, P.A. Fitzgerald, J. Pitt, and S. Pahwa Correlation between low natural killing of fibroblasts infected with herpes simplex virus type 1 and susceptibility to herpesvirus infections J Infect Dis 147 1983 1030 1035
49. E. de Vries, H.R. Koene, J.M. Vossen, J.-W. Gratama, A.E.G.K. von dem Borne, and J.L.M. Waaijer Identification of an unusual Fcg receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections Blood 88 1996 3022 3027
50. S. Jawahar, C. Moody, M. Chan, R. Finberg, R. Geha, and T. Chatila Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II) Clin Exp Immunol 103 1996 408 413
51. J.T. Grier, L.R. Forbes, L. Monaco-Shawver, J. Oshinsky, T.P. Atkinson, and C. Moody Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity J Clin Invest 122 2012 3769 3780
52. K.A. Risma, R.W. Frayer, A.H. Filipovich, and J. Sumegi Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis J Clin Invest 116 2006 182 192
53. N.N. Cac, and Z.K. Ballas Recalcitrant warts, associated with natural killer cell dysfunction, treated with systemic IFN-alpha J Allergy Clin Immunol 118 2006 526 528
54. A. Tamm, and R.E. Schmidt The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding J Immunol 157 1996 1576 1581
55. M. Lenart, E. Trzyna, M. Rutkowska, K. Bukowska-Strakova, A. Szaflarska, and A. Pituch-Noworolska The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism Int J Mol Med 26 2010 435 442
56. E.P. Zorrilla, L. Luborsky, J.R. McKay, R. Rosenthal, A. Houldin, and A. Tax The relationship of depression and stressors to immunological assays: a meta-analytic review Brain Behav Immun 15 2001 199 226
57. K. Cederbrant, M. Marcusson-Stahl, F. Condevaux, and J. Descotes NK-cell activity in immunotoxicity drug evaluation Toxicology 185 2003 241 250
58. A.M. James, H.T. Hsu, P. Dongre, G. Uzel, E.M. Mace, and P.P. Banerjee Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signaling Blood 121 2013 2627 2637
59. M.C. Mizesko, P.P. Banerjee, L. Monaco-Shawver, E.M. Mace, W.E. Bernal, and J. Sawalle-Belohradsky Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency J Allergy Clin Immunol 131 2013 840 848
60. M.J. Ombrello, E.F. Remmers, G. Sun, A.F. Freeman, S. Datta, and P. Torabi-Parizi Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions N Engl J Med 366 2012 330 338
61. R.H. Buckley, R.I. Schiff, S.E. Schiff, M.L. Markert, L.W. Williams, and T.O. Harville Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants J Pediatr 130 1997 378 387
62. J.L. Roberts, A. Lengi, S.M. Brown, M. Chen, Y.J. Zhou, and J.J. O'Shea Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation Blood 103 2004 2009 2018
63. F.D. Goldman, Z. Gurel, D. Al-Zubeidi, A.J. Fried, M. Icardi, and C. Song Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene Pediatr Blood Cancer 58 2012 591 597
64. M.D. Keller, J. Ganesh, M. Heltzer, M. Paessler, A.G. Bergqvist, and H.J. Baluarte Severe combined immunodeficiency resulting from mutations in MTHFD1 Pediatrics 131 2013 e629 e634
65. A. Bernasconi, R. Marino, A. Ribas, J. Rossi, M. Ciaccio, and M. Oleastro Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation Pediatrics 118 2006 e1584 e1592
66. A. Etzioni, N. Lahat, A. Benderly, R. Katz, and S. Pollack Humoral and cellular immune dysfunction in a patient with Bloom's syndrome and recurrent infections J Clin Lab Immunol 28 1989 151 154
67. E.T. Korthof, J. Svahn, R.P. de Latour, P. Terranova, H. Moins-Teisserenc, and G. Socie Immunological profile of Fanconi anemia: a multicentric retrospective analysis of 61 patients Am J Hematol 88 2013 472 476
68. F. Cossu, T.J. Vulliamy, A. Marrone, M. Badiali, A. Cao, and I. Dokal A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome Br J Haematol 119 2002 765 768
69. J. Feldmann, I. Callebaut, G. Raposo, S. Certain, D. Bacq, and C. Dumont Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3) Cell 115 2003 461 473
70. Y.T. Bryceson, E. Rudd, C. Zheng, J. Edner, D. Ma, and S.M. Wood Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients Blood 110 2007 1906 1915
71. M. Cote, M.M. Menager, A. Burgess, N. Mahlaoui, C. Picard, and C. Schaffner Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells J Clin Invest 119 2009 3765 3773
72. W. Introne, R.E. Boissy, and W.A. Gahl Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome Mol Genet Metab 68 1999 283 303
73. S.M. Wood, M. Meeths, S.C. Chiang, A.G. Bechensteen, J.J. Boelens, and C. Heilmann Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity Blood 114 2009 4117 4127
74. R. Badolato, and S. Parolini Novel insights from adaptor protein 3 complex deficiency J Allergy Clin Immunol 120 2007 735 743
75. R. Badolato, A. Prandini, S. Caracciolo, F. Colombo, G. Tabellini, and M. Giacomelli Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome Blood 119 2012 3185 3187
76. J.L. Meade, E.A. de Wynter, P. Brett, S.M. Sharif, C.G. Woods, and A.F. Markham A family with Papillon-Lefevre syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity Blood 107 2006 3665 3668
77. J.S. Orange, N. Ramesh, E. Remold-O'Donnell, Y. Sasahara, L. Koopman, and M. Byrne Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses Proc Natl Acad Sci U S A 99 2002 11351 11356
78. G. Lanzi, D. Moratto, D. Vairo, S. Masneri, O. Delmonte, and T. Paganini A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP J Exp Med 209 2012 29 34
79. K.B. Sanborn, E.M. Mace, G.D. Rak, A. Difeo, J.A. Martignetti, and A. Pecci Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity Blood 118 2011 5862 5871
80. R. Gruda, A.C. Brown, V. Grabovsky, S. Mizrahi, C. Gur, and S.W. Feigelson Loss of kindlin-3 alters the threshold for NK cell activation in human leukocyte adhesion deficiency-III Blood 120 2012 3915 3924
81. S.G. Tangye, J.H. Phillips, L.L. Lanier, and K.E. Nichols Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome J Immunol 165 2000 2932 2936
82. R.A. Marsh, L. Madden, B.J. Kitchen, R. Mody, B. McClimon, and M.B. Jordan XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease Blood 116 2010 1079 1082
83. K. Huck, O. Feyen, T. Niehues, F. Ruschendorf, N. Hubner, and H.J. Laws Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation J Clin Invest 119 2009 1350 1358
84. H.S. Kuehn, M.A. Beaven, H.T. Ma, M.S. Kim, D.D. Metcalfe, and A.M. Gilfillan Synergistic activation of phospholipases Cgamma and Cbeta: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release Cell Signal 20 2008 625 636
85. A. Maul-Pavicic, S.C. Chiang, A. Rensing-Ehl, B. Jessen, C. Fauriat, and S.M. Wood ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis Proc Natl Acad Sci U S A 108 2011 3324 3329
86. S. Fuchs, A. Rensing-Ehl, C. Speckmann, B. Bengsch, A. Schmitt-Graeff, and I. Bondzio Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency J Immunol 188 2012 1523 1533
87. J.S. Orange, S.R. Brodeur, A. Jain, F.A. Bonilla, L.C. Schneider, and R. Kretschmer Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations J Clin Invest 109 2002 1501 1509
88. H. Su, N. Bidere, L. Zheng, A. Cubre, K. Sakai, and J. Dale Requirement for caspase-8 in NF-kappaB activation by antigen receptor Science 307 2005 1465 1468
89. D. Vairo, L. Tassone, G. Tabellini, N. Tamassia, S. Gasperini, and F. Bazzoni Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation Blood 118 2011 1806 1817
90. H. Furukawa, T. Yabe, K. Watanabe, R. Miyamoto, A. Miki, and T. Akaza Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I) Hum Immunol 60 1999 32 40
91. G. Markel, H. Mussaffi, K.L. Ling, M. Salio, S. Gadola, and G. Steuer The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients Blood 103 2004 1770 1778
92. B.N. Jaeger, J. Donadieu, C. Cognet, C. Bernat, D. Ordonez-Rueda, and V. Barlogis Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis J Exp Med 209 2012 565 580
93. B. Ostenstad, S. Giliani, O.J. Mellbye, B.R. Nilsen, and T. Abrahamsen A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency Clin Exp Immunol 107 1997 230 234
94. E.D. Renner, D. Hartl, S. Rylaarsdam, M.L. Young, L. Monaco-Shawver, and G. Kleiner Comel-Netherton syndrome defined as primary immunodeficiency J Allergy Clin Immunol 124 2009 536 543
95. S. Guia, C. Cognet, L. de Beaucoudrey, M.S. Tessmer, E. Jouanguy, and C. Berger A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo Blood 111 2008 5008 5016
96. D. Kotlarz, N. Zietara, G. Uzel, T. Weidemann, C.J. Braun, and J. Diestelhorst Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome J Exp Med 210 2013 433 443
97. F.Y. Li, B. Chaigne-Delalande, C. Kanellopoulou, J.C. Davis, H.F. Matthews, and D.C. Douek Second messenger role for Mg2+ revealed by human T-cell immunodeficiency Nature 475 2011 471 476
98. T. Yang, M.B. Ramocki, J.L. Neul, W. Lu, L. Roberts, and J. Knight Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses Sci Transl Med 4 2012 163ra58
99. K. Goudy, D. Aydin, F. Barzaghi, E. Gambineri, M. Vignoli, and S. Ciullini Mannurita Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity Clin Immunol 146 2013 248 261
100. J. Reichenbach, R. Schubert, J. Feinberg, O. Beck, M. Rosewich, and M.A. Rose Impaired interferon-gamma production in response to live bacteria and Toll-like receptor agonists in patients with ataxia telangiectasia Clin Exp Immunol 146 2006 381 389